FrieslandCampina Ingredients launches stress and anxiety solutions through Biotis Brain Health
As the effects of the unraveling global pandemic coincide with increasingly busy lifestyles, people of all ages across the globe are more likely than ever to report feelings of poor mental wellbeing, including higher than normal levels of stress and anxiety.
According to FMCG Gurus, 42% of consumers say they would like to improve their mental wellbeing, and an Innova Consumer Lifestyle and Wellness survey this year showed 50% of people who suffer from stress say that it leads to bad moods as well as problems with fatigue and sleep.
As a result, consumers are proactively seeking natural, non-addictive solutions that fit into their daily routines.
To help brand owners respond to these challenges and to promote product development, FrieslandCampina Ingredients has developed two new consumer product applications as part of its Biotis Brain Health Benefit Solutions range.
The D-Stress sachet and Re-lax health shot are both built on FrieslandCampina Ingredients’ galacto-oligosaccharide (GOS), a dairy prebiotic shown through scientific research to stimulate the growth of gut bacteria that could help consumers feel less stressed & anxious.
“The aim of Biotis is to usher in a new era in ingredient science,” said Vicky Davies, global marketing director, performance, active and medical nutrition, at FrieslandCampina Ingredients.
“We’re looking to provide new and innovative solutions to the most current and pressing global health issues. The global COVID-19 pandemic has really put mental wellbeing in the spotlight, elevating it to the same level of importance as other aspects of physical health. As such, we’re delighted to be expanding our Biotis Brain Health Benefit Solutions offering with concepts aimed at reducing stress and anxiety, which is something we all deal with at times. We’re looking forward to working closely with our customers – old and new – to bring these much-needed solutions to life.”
Jouke Veldman, global market development manager and Biotis Brain Health lead, said, “It’s key that products on the shelves not only appeal to consumers’ key concerns and fit into their lifestyles but are also proven to be effective. Our Biotis GOS is the most researched in the world, and our most recent clinical trials show that Biotis GOS can influence the gut microbiota composition by encouraging the growth of beneficial bacteria. Through the gut-brain axis, this translates into a reduction in feelings of stress and anxiety. What’s more, our Biotis GOS are versatile and stable, which means they can work in a variety of formats, making them a solution that works both for consumers and manufacturers.”
Biotis Brain Health is part of FrieslandCampina Ingredients’ Biotis portfolio, and encompasses a range of solutions for gut and brain health, with an immune health proposition set to launch in early 2021.
“Although its only six months since Biotis and Biotis Gut Health were launched, we’re proud to have already delivered innovative solutions that resonate with both customers and consumers in a short space of time,” Davies said.
“It’s been possible thanks to our unique and detailed consumer insights and comprehensive scientific research and partnerships. Next year will see FrieslandCampina Ingredients add new propositions to the Biotis portfolio and should be a truly successful and progressive year for us and our partners as we continue to collaborate to meet the health and wellness needs of tomorrow.”
